Glenmark Pharmaceuticals Limited, a global innovation-driven pharmaceutical company, has announced the appointment of Anurag Mantri as its new President (Senior Management Personnel) and future Executive Director & Global Chief Financial Officer (CFO). This strategic leadership transition follows the decision of the current Executive Director & Global CFO, V.S. Mani, to take early retirement, effective at the close of business on May 26, 2025. To ensure a seamless handover, Mr. Mani has agreed to continue with the company for a transitional period.

The announcement, made in a regulatory filing with the Bombay Stock Exchange (BSE), signals Glenmark’s focus on bolstering its financial leadership to navigate future growth and expansion within the global healthcare landscape.

Anurag Mantri brings to Glenmark over three decades of extensive management experience across diverse sectors. His expertise spans large-scale enterprise value creation, management of significant Initial Public Offerings (IPOs), global compliance, mergers and acquisitions, and corporate finance. He also possesses a strong track record in treasury, investor relations (IR), tax management, and Enterprise Resource Planning (ERP) deployment.

Prior to joining Glenmark, Mr. Mantri served as the Executive Director & Group Chief Finance Officer at Jindal Stainless Limited since 2016, where he played a pivotal role in the company’s financial strategy and growth. His career trajectory includes impactful tenures with leading organizations such as Larsen & Toubro (Corporate Finance & Group Treasury), HCL Technologies (Corporate Treasurer), SRF Limited (Head Treasury, Investor Relations & Mergers & Acquisitions), Cairn Energy (Group Treasurer & Financial Controller, Head Investor Relations), ACME Group (Solar) (Executive Director, Finance & Strategy & Group Chief Financial Officer), and Schneider Electric Infrastructure Limited (Chief Financial Officer).

Mr. Mantri is a qualified Chartered Accountant and holds a Bachelor of Commerce degree from the University of Rajasthan. His deep financial acumen and proven leadership capabilities are expected to be instrumental in driving Glenmark’s strategic financial objectives and supporting its global business operations.

Also Read :- Dabur Appoints Sriram Padmanabhan as New Head of Health Care Business

Glenmark has stated that Mr. Mantri’s candidature for the role of Executive Director & Global Chief Financial Officer will be presented for approval to the Audit Committee, Nomination & Remuneration Committee, and the Board of Directors in their upcoming meetings. Upon receiving the necessary approvals, he will formally assume the position of Executive Director and Global Chief Financial Officer.

This appointment underscores Glenmark’s commitment to strengthening its leadership team with seasoned professionals who possess the strategic vision and financial expertise to navigate the evolving dynamics of the global pharmaceutical industry and drive sustainable growth for the company and its stakeholders. The smooth transition facilitated by Mr. Mani’s continued support will ensure business continuity and a seamless integration of the new financial leadership.

This strategic move is expected to be viewed positively by investors and partners within the healthcare industry, highlighting Glenmark’s commitment to strong financial governance and strategic leadership for sustained success.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!